RxDoctor Payments Data

Erica Cervera

Nurse Practitioner · Montgomery, WVNPI 1194995803

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $917 and has fallen 93.0% since, to $64 in 2025. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,900in general payments, 2019–2025

Across 174 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$618
  • Abbott$271
  • AstraZeneca$265
  • Novartis$248
  • GSK$237
  • AbbVie$203
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,900100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,900 in reported general payments places this provider in the 90th percentile of 649 nurse practitioner providers in West Virginia.

See all nurse practitioner providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin20$21,342
JanuviaSitagliptin Phosphate15$17,027
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,553
Albuterol Sulfate HfaAlbuterol Sulfate24$811
Metoprolol Succinate38$627
Atorvastatin Calcium60$621
Omeprazole41$465
Levothyroxine Sodium36$408
Cefdinir26$319
ClopidogrelClopidogrel Bisulfate25$271
Lisinopril47$263
Montelukast Sodium34$256
Sertraline Hcl20$248
Potassium Chloride15$213
Rosuvastatin Calcium18$202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$181$21,34220 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 649 nurse practitioner providers in West Virginia.

Other nurse practitioner in Montgomery

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →